Benzinga | Oct 28, 2020 08:19AM EDT

Citigroup Downgrades Exact Sciences to Neutral, Raises Price Target to $140

Citigroup analyst Patrick Donnelly downgrades Exact Sciences (NASDAQ:EXAS) from Buy to Neutral and raises the price target from $120 to $140.